Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions.

Shrestha RK, Sansom SL, Farnham PG.

J Public Health Manag Pract. 2012 May-Jun;18(3):259-67. doi: 10.1097/PHH.0b013e31822b2077.

PMID:
22473119
2.

Return on public health investment: CDC's Expanded HIV Testing Initiative.

Hutchinson AB, Farnham PG, Duffy N, Wolitski RJ, Sansom SL, Dooley SW, Cleveland JC, Mermin JH.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):281-6. doi: 10.1097/QAI.0b013e31823e5bee.

PMID:
22067662
3.

Estimated HIV incidence in the United States, 2006-2009.

Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F, Lin LS, An Q, Mermin J, Lansky A, Hall HI; HIV Incidence Surveillance Group.

PLoS One. 2011;6(8):e17502. doi: 10.1371/journal.pone.0017502. Epub 2011 Aug 3.

4.

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR; HPTN 052 Study Team.

N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.

5.

A model for allocating CDC's HIV prevention resources in the United States.

Lasry A, Sansom SL, Hicks KA, Uzunangelov V.

Health Care Manag Sci. 2011 Mar;14(1):115-24. doi: 10.1007/s10729-010-9147-2. Epub 2010 Dec 24.

PMID:
21184183
6.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team.

N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.

7.

Prevalence and awareness of HIV infection among men who have sex with men --- 21 cities, United States, 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Sep 24;59(37):1201-7.

8.

Optimal investment in HIV prevention programs: more is not always better.

Brandeau ML, Zaric GS.

Health Care Manag Sci. 2009 Mar;12(1):27-37.

9.

Recommendations for increasing the use of HIV/AIDS resource allocation models.

Lasry A, Richter A, Lutscher F.

BMC Public Health. 2009 Nov 18;9 Suppl 1:S8. doi: 10.1186/1471-2458-9-S1-S8.

10.

Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006.

Campsmith ML, Rhodes PH, Hall HI, Green TA.

J Acquir Immune Defic Syndr. 2010 Apr;53(5):619-24. doi: 10.1097/QAI.0b013e3181bf1c45. Erratum in: J Acquir Immune Defic Syndr. 2010 May 1;54(1):112.

PMID:
19838124
11.

Male circumcision for prevention of heterosexual acquisition of HIV in men.

Siegfried N, Muller M, Deeks JJ, Volmink J.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003362. doi: 10.1002/14651858.CD003362.pub2. Review.

12.

A brief, clinic-based, safer sex intervention for heterosexual African American men newly diagnosed with an STD: a randomized controlled trial.

Crosby R, DiClemente RJ, Charnigo R, Snow G, Troutman A.

Am J Public Health. 2009 Apr;99 Suppl 1:S96-103. doi: 10.2105/AJPH.2007.123893. Epub 2009 Feb 12.

13.

Cost-effectiveness of finding new HIV diagnoses using rapid HIV testing in community-based organizations.

Shrestha RK, Clark HA, Sansom SL, Song B, Buckendahl H, Calhoun CB, Hutchinson AB, Heffelfinger JD.

Public Health Rep. 2008 Nov-Dec;123 Suppl 3:94-100.

14.

Comparing the costs of HIV screening strategies and technologies in health-care settings.

Farnham PG, Hutchinson AB, Sansom SL, Branson BM.

Public Health Rep. 2008 Nov-Dec;123 Suppl 3:51-62.

15.

Subpopulation estimates from the HIV incidence surveillance system--United States, 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Sep 12;57(36):985-9.

16.

Understanding differences in HIV sexual transmission among Latino and black men who have sex with men: The Brothers y Hermanos Study.

Marks G, Millett GA, Bingham T, Bond L, Lauby J, Liau A, Murrill CS, Stueve A.

AIDS Behav. 2009 Aug;13(4):682-90. doi: 10.1007/s10461-008-9380-6. Epub 2008 Aug 28.

PMID:
18752064
17.

Estimation of HIV incidence in the United States.

Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS; HIV Incidence Surveillance Group.

JAMA. 2008 Aug 6;300(5):520-9. doi: 10.1001/jama.300.5.520.

18.

Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002.

Brady JE, Friedman SR, Cooper HL, Flom PL, Tempalski B, Gostnell K.

J Urban Health. 2008 May;85(3):323-51. doi: 10.1007/s11524-007-9248-5. Epub 2008 Mar 15.

19.

A cost function for HIV prevention services: is there a 'u' - shape?

Guinness L, Kumaranayake L, Hanson K.

Cost Eff Resour Alloc. 2007 Nov 5;5:13.

20.

Effects on sexual risk behavior and STD rate of brief HIV/STD prevention interventions for African American women in primary care settings.

Jemmott LS, Jemmott JB 3rd, O'Leary A.

Am J Public Health. 2007 Jun;97(6):1034-40. Epub 2007 Apr 26.

Supplemental Content

Support Center